Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2693]
News [7459]
Articles [306]
Editorials [8]
Conferences [227]
elearning [48]
Latest trials and outcomes with new CLL treatments
Dr George Follows and Professor Peter Hillmen
Latest trials and outcomes with new CLL treatments ( Dr George Follows and Professor Peter Hillmen )
29 Apr 2015
The evolution of CLL treatment
Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence...
The evolution of CLL treatment ( Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista )
28 Apr 2015
US breast cancer cases expected to increase by as much as 50 percent by 2030
Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National...
US breast cancer cases expected to increase by as much as 50 percent by 2030 ( Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA )
27 Apr 2015
How to decide the treatment of CLL in 2015
Dr Marco Montillo and Dr Maria Gomes da Silva
How to decide the treatment of CLL in 2015 ( Dr Marco Montillo and Dr Maria Gomes da Silva )
24 Apr 2015
ecancermedicalscience editor's choice for March 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for March 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
9 Apr 2015
Taxane response in prostate cancer may not be influenced by androgen receptor...
Dr Emmanuel Antonarakis - Johns Hopkins School of Medicine, Baltimore, USA
Taxane response in prostate cancer may not be influenced by androgen receptor variations ( Dr Emmanuel Antonarakis - Johns Hopkins School of Medicine, Baltimore, USA )
28 Feb 2015
Combination of dalantercept plus axitinib versus placebo plus axitinib in...
Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA
Combination of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma ( Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA )
28 Feb 2015
Genomic profiling may reveal new drug targets in urothelial carcinoma
Dr Jeffrey Ross - Albany Medical College, Albany, USA
Genomic profiling may reveal new drug targets in urothelial carcinoma ( Dr Jeffrey Ross - Albany Medical College, Albany, USA )
27 Feb 2015
Combination of abiraterone and cabazitaxel in metastatic castration-resistant...
Dr Joaquin Mateo - Institute of Cancer Research, London, UK
Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer ( Dr Joaquin Mateo - Institute of Cancer Research, London, UK )
27 Feb 2015
Is there a role for androgen deprivation therapy combined with radiotherapy in...
Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer? ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
27 Feb 2015
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial...
Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer ( Dr Arlene Siefker-Radtke - MD Anderson Cancer Centre, Houston, USA )
27 Feb 2015
New approach to prostate cancer screening
Dr Sanoj Punnen - University of Miami, Miami, USA
New approach to prostate cancer screening ( Dr Sanoj Punnen - University of Miami, Miami, USA )
27 Feb 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation